Berry-Kravis E - Search Results

1

Altered steady state and activity-dependent de novo protein expression in fragile X syndrome.

Bowling H, Bhattacharya A, Zhang G, Alam D, Lebowitz JZ, Bohm-Levine N, Lin D, Singha P, Mamcarz M, Puckett R, Zhou L, Aryal S, Sharp K, Kirshenbaum K, Berry-Kravis E, Neubert TA, Klann E. Bowling H, et al. Nat Commun. 2019 Apr 12;10(1):1710. doi: 10.1038/s41467-019-09553-8. Nat Commun. 2019. PMID: 30979884 Free PMC article.

2

Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome.

Berry-Kravis E, Sklena P. Berry-Kravis E, et al. Am J Med Genet. 1993 Jan 1;45(1):81-7. doi: 10.1002/ajmg.1320450120. Am J Med Genet. 1993. PMID: 8380312

3

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.

Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Goldman JG, et al. Arch Neurol. 2004 Aug;61(8):1280-4. doi: 10.1001/archneur.61.8.1280. Arch Neurol. 2004. PMID: 15313848

4

Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation.

Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. Berry-Kravis E, et al. Ann Neurol. 2005 Jan;57(1):144-7. doi: 10.1002/ana.20360. Ann Neurol. 2005. PMID: 15622531

5

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.

Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, Weiler IJ, Greenough WT. Berry-Kravis E, et al. J Dev Behav Pediatr. 2008 Aug;29(4):293-302. doi: 10.1097/DBP.0b013e31817dc447. J Dev Behav Pediatr. 2008. PMID: 18698192 Clinical Trial.

6

Development of an expressive language sampling procedure in fragile X syndrome: a pilot study.

Berry-Kravis E, Doll E, Sterling A, Kover ST, Schroeder SM, Mathur S, Abbeduto L. Berry-Kravis E, et al. J Dev Behav Pediatr. 2013 May;34(4):245-51. doi: 10.1097/DBP.0b013e31828742fc. J Dev Behav Pediatr. 2013. PMID: 23669871 Free PMC article.

7

Outcome measures for clinical trials in fragile X syndrome.

Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK; Outcome Measures Working Groups. Berry-Kravis E, et al. J Dev Behav Pediatr. 2013 Sep;34(7):508-22. doi: 10.1097/DBP.0b013e31829d1f20. J Dev Behav Pediatr. 2013. PMID: 24042082 Free PMC article.

8

Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.

Berry-Kravis E. Berry-Kravis E. Pediatr Neurol. 2014 Apr;50(4):297-302. doi: 10.1016/j.pediatrneurol.2013.12.001. Epub 2013 Dec 4. Pediatr Neurol. 2014. PMID: 24518745 Review.

9

Autism and fragile X syndrome.

Yu TW, Berry-Kravis E. Yu TW, et al. Semin Neurol. 2014 Jul;34(3):258-65. doi: 10.1055/s-0034-1386764. Epub 2014 Sep 5. Semin Neurol. 2014. PMID: 25192504 Review.

10

Cholesterol levels in fragile X syndrome.

Berry-Kravis E, Levin R, Shah H, Mathur S, Darnell JC, Ouyang B. Berry-Kravis E, et al. Am J Med Genet A. 2015 Feb;167A(2):379-84. doi: 10.1002/ajmg.a.36850. Epub 2014 Nov 25. Am J Med Genet A. 2015. PMID: 25424470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters